Teva Pharmaceutical Industries' chairman Yitzhak Peterburg has been appointed interim president and chief executive officer. Read More »

Purdue Pharma LP has named Margaret Feltz vice president and chief ethics/compliance officer, reporting to President and CEO Mark Timney. Read More »

Takeda Pharmaceuticals U.S.A. Inc. recently welcomed Catherine Pugh, the mayor of Baltimore, to its Chicago office to celebrate Black History Month. Read More »

Precision for Value has named Dr. Maureen Hennessey, senior vice president and director of quality and population health systems, to the National Quality Forum’s Medicaid Innovation Accelerator Project 2016-2017. Read More »

Mark Jackson has been appointed vice president of Quality for Noven Pharmaceuticals Inc. Read More »

RXi Pharmaceuticals Corp. has named Dr. Rolf Kiessling, professor in experimental oncology at Karolinska Institutet, to its Scientific Advisory Board. Read More »

Charles Holley Jr. has joined the Amgen Board of Directors as a member of the Audit Committee and the Corporate Responsibility and Compliance Committee.  Read More »

CTI BioPharma Corp., a company that specializes in developing blood cancer treatments, has named Michael Metzger its new director. Read More »

Mylan CEO Heather Bresch presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Read More »

Dova Pharmaceuticals Inc., a clinical, late-stage company, recently named Alex Sapir as its new CEO. Read More »

Dr. Ciara Kennedy has been named president and chief executive officer of Amplyx Pharmaceuticals, a company that develops novel antifungal agents for life-threatening fungal infections. Read More »

Dr. Dan Iosifescu, a well-known clinician-specialist specializing in mood disorders, has joined NYU Langone Medical Center's psychiatry faculty. Read More »

CVS Health Corp. President and CEO Larry Merlo spoke to investors this week at the 35th Annual J.P. Morgan Healthcare Conference. Read More »

Bayer recently announced the selection of Robert LaCaze as executive vice president in charge of the company’s new Oncology Strategic Business Unit at the Pharmaceuticals Division. Read More »

Pernix Therapeutics Holdings Inc., a pharmaceutical company specializing in pain and central nervous system conditions, recently appointed Gabriel Leung to its board of directors. Read More »

Zavante Therapeutics, a privately owned biopharmaceutical company that conducts late-stage clinical trials, has appointed eight infectious disease specialists to serve on its newly formed Scientific Advisory Board. Read More »

Crown Bioscience, a subsidiary of Crown Bioscience International and a worldwide global drug discovery and development services company that provides translational platforms that improve the research of oncology and metabolic diseases, has named Dr. Jean Pierre Wery its CEO. Read More »

Akebia Therapeutics Inc. and Otsuka Pharmaceutical Co. Ltd. recently entered a collaboration and license agreement in the U.S. for vadadustat, an oral hypoxia-inducible factor stabilizer in development for the treatment of anemia associated with chronic kidney disease Read More »

Incyte Corp. and Merus N.V. have a new partnership to study and develop a platform around bispecific antibodies using Merus’ proprietary Biclonics technology platform. Read More »

Prime Therapeutics LLC, a pharmacy benefit manager with more than 22 million customers across the nation, recently named John Drakulich as its new chief sales officer. Read More »